TABLE OF CONTENTS 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Viral Vector and Plasmid DNA 1.2 Key Market Segments 1.2.1 Viral Vector and Plasmid DNA Segment by Type 1.2.2 Viral Vector and Plasmid DNA Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Viral Vector and Plasmid DNA Market Overview 2.1 Global Viral Vector and Plasmid DNA Market Size (M USD) Estimates and Forecasts (2017-2028) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Viral Vector and Plasmid DNA Market Competitive Landscape 3.1 Global Viral Vector and Plasmid DNA Revenue Market Share by Manufacturers (2017-2022) 3.2 Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Manufacturers Viral Vector and Plasmid DNA Sales Sites, Area Served, Service Type 3.4 Viral Vector and Plasmid DNA Market Competitive Situation and Trends 3.4.1 Viral Vector and Plasmid DNA Market Concentration Rate 3.4.2 Global 5 and 10 Largest Viral Vector and Plasmid DNA Players Market Share by Revenue 3.4.3 Mergers & Acquisitions, Expansion 4 Viral Vector and Plasmid DNA Value Chain Analysis 4.1 Viral Vector and Plasmid DNA Value Chain Analysis 4.2 Midstream Market Analysis 4.3 Downstream Customer Analysis 5 The Development and Dynamics of Viral Vector and Plasmid DNA Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 Mergers & Acquisitions 5.5.2 Expansions 5.5.3 Collaboration/Supply Contracts 5.6 Industry Policies 6 Viral Vector and Plasmid DNA Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Viral Vector and Plasmid DNA Market Size Market Share by Type (2017-2022) 6.3 Global Viral Vector and Plasmid DNA Sales Growth Rate by Type (2017-2022) 7 Viral Vector and Plasmid DNA Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Viral Vector and Plasmid DNA Market Size (M USD) by Application (2017-2022) 7.3 Global Viral Vector and Plasmid DNA Sales Growth Rate by Application (2017-2022) 8 Viral Vector and Plasmid DNA Market Segmentation by Region 8.1 Global Viral Vector and Plasmid DNA Market Size by Region 8.1.1 Global Viral Vector and Plasmid DNA Market Size by Region 8.1.2 Global Viral Vector and Plasmid DNA Market Share by Region 8.2 North America 8.2.1 North America Viral Vector and Plasmid DNA Market Size by Country 8.2.2 U.S. 8.2.3 Canada 8.2.4 Mexico 8.3 Europe 8.3.1 Europe Viral Vector and Plasmid DNA Market Size by Country 8.3.2 Germany 8.3.3 France 8.3.4 U.K. 8.3.5 Italy 8.3.6 Russia 8.4 Asia Pacific 8.4.1 Asia Pacific Viral Vector and Plasmid DNA Market Size by Region 8.4.2 China 8.4.3 Japan 8.4.4 South Korea 8.4.5 India 8.4.6 Southeast Asia 8.5 South America 8.5.1 South America Viral Vector and Plasmid DNA Market Size by Country 8.5.2 Brazil 8.5.3 Argentina 8.5.4 Columbia 8.6 Middle East and Africa 8.6.1 Middle East and Africa Viral Vector and Plasmid DNA Market Size by Region 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Egypt 8.6.5 Nigeria 8.6.6 South Africa 9 Key Companies Profiled 9.1 Brammer Bio 9.1.1 Brammer Bio Viral Vector and Plasmid DNA Basic Information 9.1.2 Brammer Bio Viral Vector and Plasmid DNA Product Overview 9.1.3 Brammer Bio Viral Vector and Plasmid DNA Product Market Performance 9.1.4 Brammer Bio Business Overview 9.1.5 Brammer Bio Viral Vector and Plasmid DNA SWOT Analysis 9.1.6 Brammer Bio Recent Developments 9.2 Oxford BioMedica 9.2.1 Oxford BioMedica Viral Vector and Plasmid DNA Basic Information 9.2.2 Oxford BioMedica Viral Vector and Plasmid DNA Product Overview 9.2.3 Oxford BioMedica Viral Vector and Plasmid DNA Product Market Performance 9.2.4 Oxford BioMedica Business Overview 9.2.5 Oxford BioMedica Viral Vector and Plasmid DNA SWOT Analysis 9.2.6 Oxford BioMedica Recent Developments 9.3 Cobra Biologics 9.3.1 Cobra Biologics Viral Vector and Plasmid DNA Basic Information 9.3.2 Cobra Biologics Viral Vector and Plasmid DNA Product Overview 9.3.3 Cobra Biologics Viral Vector and Plasmid DNA Product Market Performance 9.3.4 Cobra Biologics Business Overview 9.3.5 Cobra Biologics Viral Vector and Plasmid DNA SWOT Analysis 9.3.6 Cobra Biologics Recent Developments 9.4 FinVector 9.4.1 FinVector Viral Vector and Plasmid DNA Basic Information 9.4.2 FinVector Viral Vector and Plasmid DNA Product Overview 9.4.3 FinVector Viral Vector and Plasmid DNA Product Market Performance 9.4.4 FinVector Business Overview 9.4.5 FinVector Viral Vector and Plasmid DNA SWOT Analysis 9.4.6 FinVector Recent Developments 9.5 Lonza 9.5.1 Lonza Viral Vector and Plasmid DNA Basic Information 9.5.2 Lonza Viral Vector and Plasmid DNA Product Overview 9.5.3 Lonza Viral Vector and Plasmid DNA Product Market Performance 9.5.4 Lonza Business Overview 9.5.5 Lonza Viral Vector and Plasmid DNA SWOT Analysis 9.5.6 Lonza Recent Developments 9.6 BioReliance 9.6.1 BioReliance Viral Vector and Plasmid DNA Basic Information 9.6.2 BioReliance Viral Vector and Plasmid DNA Product Overview 9.6.3 BioReliance Viral Vector and Plasmid DNA Product Market Performance 9.6.4 BioReliance Business Overview 9.6.5 BioReliance Recent Developments 9.7 MolMed 9.7.1 MolMed Viral Vector and Plasmid DNA Basic Information 9.7.2 MolMed Viral Vector and Plasmid DNA Product Overview 9.7.3 MolMed Viral Vector and Plasmid DNA Product Market Performance 9.7.4 MolMed Business Overview 9.7.5 MolMed Recent Developments 9.8 FUJIFILM Diosynth Biotechnologies 9.8.1 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Basic Information 9.8.2 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Overview 9.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Market Performance 9.8.4 FUJIFILM Diosynth Biotechnologies Business Overview 9.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments 9.9 UniQure 9.9.1 UniQure Viral Vector and Plasmid DNA Basic Information 9.9.2 UniQure Viral Vector and Plasmid DNA Product Overview 9.9.3 UniQure Viral Vector and Plasmid DNA Product Market Performance 9.9.4 UniQure Business Overview 9.9.5 UniQure Recent Developments 9.10 Aldevron 9.10.1 Aldevron Viral Vector and Plasmid DNA Basic Information 9.10.2 Aldevron Viral Vector and Plasmid DNA Product Overview 9.10.3 Aldevron Viral Vector and Plasmid DNA Product Market Performance 9.10.4 Aldevron Business Overview 9.10.5 Aldevron Recent Developments 9.11 Richter-Helm 9.11.1 Richter-Helm Viral Vector and Plasmid DNA Basic Information 9.11.2 Richter-Helm Viral Vector and Plasmid DNA Product Overview 9.11.3 Richter-Helm Viral Vector and Plasmid DNA Product Market Performance 9.11.4 Richter-Helm Business Overview 9.11.5 Richter-Helm Recent Developments 9.12 Eurogentec 9.12.1 Eurogentec Viral Vector and Plasmid DNA Basic Information 9.12.2 Eurogentec Viral Vector and Plasmid DNA Product Overview 9.12.3 Eurogentec Viral Vector and Plasmid DNA Product Market Performance 9.12.4 Eurogentec Business Overview 9.12.5 Eurogentec Recent Developments 9.13 OBiO Technology 9.13.1 OBiO Technology Viral Vector and Plasmid DNA Basic Information 9.13.2 OBiO Technology Viral Vector and Plasmid DNA Product Overview 9.13.3 OBiO Technology Viral Vector and Plasmid DNA Product Market Performance 9.13.4 OBiO Technology Business Overview 9.13.5 OBiO Technology Recent Developments 9.14 Yposkesi 9.14.1 Yposkesi Viral Vector and Plasmid DNA Basic Information 9.14.2 Yposkesi Viral Vector and Plasmid DNA Product Overview 9.14.3 Yposkesi Viral Vector and Plasmid DNA Product Market Performance 9.14.4 Yposkesi Business Overview 9.14.5 Yposkesi Recent Developments 9.15 Cell and Gene Therapy Catapult 9.15.1 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Basic Information 9.15.2 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Overview 9.15.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Market Performance 9.15.4 Cell and Gene Therapy Catapult Business Overview 9.15.5 Cell and Gene Therapy Catapult Recent Developments 9.16 MassBiologics 9.16.1 MassBiologics Viral Vector and Plasmid DNA Basic Information 9.16.2 MassBiologics Viral Vector and Plasmid DNA Product Overview 9.16.3 MassBiologics Viral Vector and Plasmid DNA Product Market Performance 9.16.4 MassBiologics Business Overview 9.16.5 MassBiologics Recent Developments 9.17 Biovian 9.17.1 Biovian Viral Vector and Plasmid DNA Basic Information 9.17.2 Biovian Viral Vector and Plasmid DNA Product Overview 9.17.3 Biovian Viral Vector and Plasmid DNA Product Market Performance 9.17.4 Biovian Business Overview 9.17.5 Biovian Recent Developments 9.18 VGXI 9.18.1 VGXI Viral Vector and Plasmid DNA Basic Information 9.18.2 VGXI Viral Vector and Plasmid DNA Product Overview 9.18.3 VGXI Viral Vector and Plasmid DNA Product Market Performance 9.18.4 VGXI Business Overview 9.18.5 VGXI Recent Developments 9.19 Gene Synthesis 9.19.1 Gene Synthesis Viral Vector and Plasmid DNA Basic Information 9.19.2 Gene Synthesis Viral Vector and Plasmid DNA Product Overview 9.19.3 Gene Synthesis Viral Vector and Plasmid DNA Product Market Performance 9.19.4 Gene Synthesis Business Overview 9.19.5 Gene Synthesis Recent Developments 9.20 PlasmidFactory 9.20.1 PlasmidFactory Viral Vector and Plasmid DNA Basic Information 9.20.2 PlasmidFactory Viral Vector and Plasmid DNA Product Overview 9.20.3 PlasmidFactory Viral Vector and Plasmid DNA Product Market Performance 9.20.4 PlasmidFactory Business Overview 9.20.5 PlasmidFactory Recent Developments 9.21 Jikai Gene 9.21.1 Jikai Gene Viral Vector and Plasmid DNA Basic Information 9.21.2 Jikai Gene Viral Vector and Plasmid DNA Product Overview 9.21.3 Jikai Gene Viral Vector and Plasmid DNA Product Market Performance 9.21.4 Jikai Gene Business Overview 9.21.5 Jikai Gene Recent Developments 10 Viral Vector and Plasmid DNA Regional Market Forecast 10.1 Global Viral Vector and Plasmid DNA Market Size Forecast 10.2 Global Viral Vector and Plasmid DNA Market Forecast by Region 10.2.1 North America Market Size Forecast by Country 10.2.2 Europe Viral Vector and Plasmid DNA Market Size Forecast by Country 10.2.3 Asia Pacific Viral Vector and Plasmid DNA Market Size Forecast by Region 10.2.4 South America Viral Vector and Plasmid DNA Market Size Forecast by Country 10.2.5 Middle East and Africa Forecasted Consumption of Viral Vector and Plasmid DNA by Country 11 Market Segmentation & Size Forecast (2023-2028) 11.1 Global Viral Vector and Plasmid DNA Market Forecast by Type (2023-2028) 11.2 Global Viral Vector and Plasmid DNA Market Forecast by Application (2023-2028) 12 Conclusion and Key Findings

LIST OF TABLES Table 1. Introduction of the Type Table 2. Introduction of the Application Table 3. Market Size (M USD) Segment Executive Summary Table 4. Viral Vector and Plasmid DNA Market Size (M USD) Comparison by Region (M USD) Table 5. Global Viral Vector and Plasmid DNA Revenue (M USD) by Manufacturers (2017-2022) Table 6. Global Viral Vector and Plasmid DNA Revenue Share by Manufacturers (2017-2022) Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Plasmid DNA as of 2021) Table 8. Manufacturers Viral Vector and Plasmid DNA Sales Sites and Area Served Table 9. Manufacturers Viral Vector and Plasmid DNA Service Type Table 10. Global Viral Vector and Plasmid DNA Manufacturers Market Concentration Ratio (CR5 and HHI) Table 11. Mergers & Acquisitions, Expansion Plans Table 12. Value Chain Map of Viral Vector and Plasmid DNA Table 13. Midstream Market Analysis Table 14. Downstream Customer Analysis Table 15. Key Development Trends Table 16. Driving Factors Table 17. Viral Vector and Plasmid DNA Market Challenges Table 18. Market Restraints Table 19. Global Viral Vector and Plasmid DNA Market Size by Type (M USD) Table 20. Global Viral Vector and Plasmid DNA Market Size (M USD) by Type (2017-2022) Table 21. Global Viral Vector and Plasmid DNA Market Size Share by Type (2017-2022) Table 22. Global Viral Vector and Plasmid DNA Sales Growth Rate by Type (2017-2022) Table 23. Global Viral Vector and Plasmid DNA Sales (K Units) by Application Table 24. Global Viral Vector and Plasmid DNA Market Size by Application Table 25. Global Viral Vector and Plasmid DNA Sales by Application (2017-2022) & (M USD) Table 26. Global Viral Vector and Plasmid DNA Market Share by Application (2017-2022) Table 27. Global Viral Vector and Plasmid DNA Sales Growth Rate by Application (2017-2022) Table 28. Global Viral Vector and Plasmid DNA Market Size by Region (2017-2022) & (M USD) Table 29. Global Viral Vector and Plasmid DNA Market Share by Region (2017-2022) Table 30. North America Viral Vector and Plasmid DNA Market Size by Country (2017-2022) & (M USD) Table 31. Europe Viral Vector and Plasmid DNA Market Size by Country (2017-2022) & (M USD) Table 32. Asia Pacific Viral Vector and Plasmid DNA Market Size by Region (2017-2022) & (M USD) Table 33. South America Viral Vector and Plasmid DNA Market Size by Country (2017-2022) & (M USD) Table 34. Middle East and Africa Viral Vector and Plasmid DNA Market Size by Region (2017-2022) & (M USD) Table 35. Brammer Bio Viral Vector and Plasmid DNA Basic Information Table 36. Brammer Bio Viral Vector and Plasmid DNA Product Overview Table 37. Brammer Bio Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 38. Brammer Bio Business Overview Table 39. Brammer Bio Viral Vector and Plasmid DNA SWOT Analysis Table 40. Brammer Bio Recent Developments Table 41. Oxford BioMedica Viral Vector and Plasmid DNA Basic Information Table 42. Oxford BioMedica Viral Vector and Plasmid DNA Product Overview Table 43. Oxford BioMedica Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 44. Oxford BioMedica Business Overview Table 45. Oxford BioMedica Viral Vector and Plasmid DNA SWOT Analysis Table 46. Oxford BioMedica Recent Developments Table 47. Cobra Biologics Viral Vector and Plasmid DNA Basic Information Table 48. Cobra Biologics Viral Vector and Plasmid DNA Product Overview Table 49. Cobra Biologics Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 50. Cobra Biologics Business Overview Table 51. Cobra Biologics Viral Vector and Plasmid DNA SWOT Analysis Table 52. Cobra Biologics Recent Developments Table 53. FinVector Viral Vector and Plasmid DNA Basic Information Table 54. FinVector Viral Vector and Plasmid DNA Product Overview Table 55. FinVector Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 56. FinVector Business Overview Table 57. FinVector Viral Vector and Plasmid DNA SWOT Analysis Table 58. FinVector Recent Developments Table 59. Lonza Viral Vector and Plasmid DNA Basic Information Table 60. Lonza Viral Vector and Plasmid DNA Product Overview Table 61. Lonza Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 62. Lonza Business Overview Table 63. Lonza Viral Vector and Plasmid DNA SWOT Analysis Table 64. Lonza Recent Developments Table 65. BioReliance Viral Vector and Plasmid DNA Basic Information Table 66. BioReliance Viral Vector and Plasmid DNA Product Overview Table 67. BioReliance Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 68. BioReliance Business Overview Table 69. BioReliance Recent Developments Table 70. MolMed Viral Vector and Plasmid DNA Basic Information Table 71. MolMed Viral Vector and Plasmid DNA Product Overview Table 72. MolMed Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 73. MolMed Business Overview Table 74. MolMed Recent Developments Table 75. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Basic Information Table 76. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product Overview Table 77. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 78. FUJIFILM Diosynth Biotechnologies Business Overview Table 79. FUJIFILM Diosynth Biotechnologies Recent Developments Table 80. UniQure Viral Vector and Plasmid DNA Basic Information Table 81. UniQure Viral Vector and Plasmid DNA Product Overview Table 82. UniQure Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 83. UniQure Business Overview Table 84. UniQure Recent Developments Table 85. Aldevron Viral Vector and Plasmid DNA Basic Information Table 86. Aldevron Viral Vector and Plasmid DNA Product Overview Table 87. Aldevron Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 88. Aldevron Business Overview Table 89. Aldevron Recent Developments Table 90. Richter-Helm Viral Vector and Plasmid DNA Basic Information Table 91. Richter-Helm Viral Vector and Plasmid DNA Product Overview Table 92. Richter-Helm Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 93. Richter-Helm Business Overview Table 94. Richter-Helm Recent Developments Table 95. Eurogentec Viral Vector and Plasmid DNA Basic Information Table 96. Eurogentec Viral Vector and Plasmid DNA Product Overview Table 97. Eurogentec Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 98. Eurogentec Business Overview Table 99. Eurogentec Recent Developments Table 100. OBiO Technology Viral Vector and Plasmid DNA Basic Information Table 101. OBiO Technology Viral Vector and Plasmid DNA Product Overview Table 102. OBiO Technology Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 103. OBiO Technology Business Overview Table 104. OBiO Technology Recent Developments Table 105. Yposkesi Viral Vector and Plasmid DNA Basic Information Table 106. Yposkesi Viral Vector and Plasmid DNA Product Overview Table 107. Yposkesi Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 108. Yposkesi Business Overview Table 109. Yposkesi Recent Developments Table 110. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Basic Information Table 111. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product Overview Table 112. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 113. Cell and Gene Therapy Catapult Business Overview Table 114. Cell and Gene Therapy Catapult Recent Developments Table 115. MassBiologics Viral Vector and Plasmid DNA Basic Information Table 116. MassBiologics Viral Vector and Plasmid DNA Product Overview Table 117. MassBiologics Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 118. MassBiologics Business Overview Table 119. MassBiologics Recent Developments Table 120. Biovian Viral Vector and Plasmid DNA Basic Information Table 121. Biovian Viral Vector and Plasmid DNA Product Overview Table 122. Biovian Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 123. Biovian Business Overview Table 124. Biovian Recent Developments Table 125. VGXI Viral Vector and Plasmid DNA Basic Information Table 126. VGXI Viral Vector and Plasmid DNA Product Overview Table 127. VGXI Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 128. VGXI Business Overview Table 129. VGXI Recent Developments Table 130. Gene Synthesis Viral Vector and Plasmid DNA Basic Information Table 131. Gene Synthesis Viral Vector and Plasmid DNA Product Overview Table 132. Gene Synthesis Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 133. Gene Synthesis Business Overview Table 134. Gene Synthesis Recent Developments Table 135. PlasmidFactory Viral Vector and Plasmid DNA Basic Information Table 136. PlasmidFactory Viral Vector and Plasmid DNA Product Overview Table 137. PlasmidFactory Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 138. PlasmidFactory Business Overview Table 139. PlasmidFactory Recent Developments Table 140. Jikai Gene Viral Vector and Plasmid DNA Basic Information Table 141. Jikai Gene Viral Vector and Plasmid DNA Product Overview Table 142. Jikai Gene Viral Vector and Plasmid DNA Revenue (M USD) and Gross Margin (2017-2022) Table 143. Jikai Gene Business Overview Table 144. Jikai Gene Recent Developments Table 145. Global Viral Vector and Plasmid DNA Market Size Forecast by Region (M USD) Table 146. North America Viral Vector and Plasmid DNA Market Size Forecast by Country (2023-2028) & (M USD) Table 147. Europe Viral Vector and Plasmid DNA Market Size Forecast by Country (2023-2028) & (M USD) Table 148. Asia Pacific Viral Vector and Plasmid DNA Market Size Forecast by Region (2023-2028) & (M USD) Table 149. South America Viral Vector and Plasmid DNA Market Size Forecast by Country (2023-2028) & (M USD) Table 150. Middle East and Africa Viral Vector and Plasmid DNA Market Size Forecast by Country (2023-2028) & (M USD) Table 151. Global Viral Vector and Plasmid DNA Market Size Forecast by Type (2023-2028) & (M USD) Table 152. Global Viral Vector and Plasmid DNA Market Size Forecast by Application (2023-2028) & (M USD) LIST OF FIGURES Figure 1. Industrial Chain of Viral Vector and Plasmid DNA Figure 2. Data Triangulation Figure 3. Key Caveats Figure 4. Global Viral Vector and Plasmid DNA Market Size (M USD), 2017-2028 Figure 5. Global Viral Vector and Plasmid DNA Market Size (M USD) (2017-2028) Figure 6. Evaluation Matrix of Segment Market Development Potential (Type) Figure 7. Evaluation Matrix of Segment Market Development Potential (Application) Figure 8. Evaluation Matrix of Regional Market Development Potential Figure 9. Viral Vector and Plasmid DNA Market Size (M USD) by Country (M USD) Figure 10. Global Viral Vector and Plasmid DNA Revenue Share by Manufacturers in 2021 Figure 11. Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 12. The Global 5 and 10 Largest Players: Market Share by Viral Vector and Plasmid DNA Revenue in 2021 Figure 13. Evaluation Matrix of Segment Market Development Potential (Type) Figure 14. Global Viral Vector and Plasmid DNA Market Share by Type Figure 15. Market Size Share of Viral Vector and Plasmid DNA by Type (2017-2022) Figure 16. Market Size Market Share of Viral Vector and Plasmid DNA by Type in 2021 Figure 17. Global Viral Vector and Plasmid DNA Sales Growth Rate by Type (2017-2022) Figure 18. Global Viral Vector and Plasmid DNA Market Share by Application Figure 19. Global Viral Vector and Plasmid DNA Market Share by Application (2017-2022) Figure 20. Global Viral Vector and Plasmid DNA Market Share by Application in 2021 Figure 21. Global Viral Vector and Plasmid DNA Sales Growth Rate by Application (2017-2022) Figure 22. Global Viral Vector and Plasmid DNA Market Share by Region (2017-2022) Figure 23. North America Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 24. North America Viral Vector and Plasmid DNA Market Share by Country in 2021 Figure 25. U.S. Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 26. Canada Viral Vector and Plasmid DNA Market Size (M USD) and Growth Rate (2017-2022) Figure 27. Mexico Viral Vector and Plasmid DNA Market Size (Units) and Growth Rate (2017-2022) Figure 28. Europe Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 29. Europe Viral Vector and Plasmid DNA Market Share by Country in 2021 Figure 30. Germany Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 31. France Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 32. U.K. Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 33. Italy Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 34. Russia Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 35. Asia Pacific Viral Vector and Plasmid DNA Market Size and Growth Rate (M USD) Figure 36. Asia Pacific Viral Vector and Plasmid DNA Market Share by Region in 2021 Figure 37. China Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 38. Japan Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 39. South Korea Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 40. India Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 41. Southeast Asia Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 42. South America Viral Vector and Plasmid DNA Market Size and Growth Rate (M USD) Figure 43. South America Viral Vector and Plasmid DNA Market Share by Country in 2021 Figure 44. Brazil Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 45. Argentina Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 46. Columbia Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 47. Middle East and Africa Viral Vector and Plasmid DNA Market Size and Growth Rate (M USD) Figure 48. Middle East and Africa Viral Vector and Plasmid DNA Market Share by Region in 2021 Figure 49. Saudi Arabia Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 50. UAE Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 51. Egypt Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 52. Nigeria Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 53. South Africa Viral Vector and Plasmid DNA Market Size and Growth Rate (2017-2022) & (M USD) Figure 54. Global Viral Vector and Plasmid DNA Market Size Forecast by Value (2017-2028) & (M USD) Figure 55. Global Viral Vector and Plasmid DNA Market Share Forecast by Type (2023-2028) Figure 56. Global Viral Vector and Plasmid DNA Market Share Forecast by Application (2023-2028)

•Brammer Bio •Oxford BioMedica •Cobra Biologics •FinVector •Lonza •BioReliance •MolMed •FUJIFILM Diosynth Biotechnologies •UniQure •Aldevron •Richter-Helm •Eurogentec •OBiO Technology •Yposkesi •Cell and Gene Therapy Catapult •MassBiologics •Biovian •VGXI •Gene Synthesis •PlasmidFactory •Jikai Gene